Projects

ENABLE: smart solutions for a better health

Work

Project

Medication non-adherence is a major societal problem with serious clinical and economic consequences, associated with 200,000 deaths and 125 billion Euros of costs annually in Europe.

Studies show that only about half of patients take their medicines as prescribed, leading to poor clinical outcomes and increased hospital admissions: this phenomenon is called medication non-adherence.

In recent years, various solutions have been developed to help patients take their medication as prescribed. Known as Medication Adherence Technologies (MATech), these include electronic devices that track medication intake, dose dispensers with instructions, and mobile applications that provide health information and reminders.

 

Client

The COST Action European Network to Advance Best Practices & Technology on Medication Adherence (ENABLE) addresses medication non-adherence by engaging the private sector to promote innovative technology-based solutions.

ENABLE is developing a knowledge base and promoting local “Medication Adherence Expertise Centres” to pool multidisciplinary knowledge at regional and national levels. By connecting technology engineers with healthcare providers, patients and payers, ENABLE aims to create a fully integrated and personalised adherence strategy.

Artist

Fiammetta Ghedini

Fiammetta Ghedini is the co-founder of RIVA Illustrations. After completing her PhD in Cognitive Sciences in 2011, she worked as the editorial coordinator of the European research communication project ERCcOMICS (2015–2019), which used comics to make cutting-edge science accessible to a wider audience.

Since 2019, she has been working as an artist and science communicator at RIVA Illustrations, creating illustrations, graphic novels, and visual narratives that bridge art and research.

In 2025, she published her first comic book with Dargaud, titled Une Insatiable Envie de Douceur, a thought-provoking and visually rich exploration of our complex relationship with sugar.

Interesting ? Let's talk !

Contact us

Interesting ? Let's talk !

Contact us